In breast cancer, it has been reported to be expressed in both tumour cells and T cells, and an inverse correlation between CTLA4 expression and clinical outcome has been previously reported in 60 patients with different breast cancer subtypes [29]. The gene discussed is CTLA4; the disease is breast carcinoma.